Stocks
Dolby Laboratories Financial Statements (DLB) |
||||||||||
| Dolby Laboratoriessmart-lab.ru | % | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 17.11.2023 | 02.02.2024 | 02.05.2024 | 07.08.2024 | 19.11.2024 | 19.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 290.6 | 315.6 | 364.5 | 288.8 | 304.8 | 1 274 | |||
| Operating Income, bln rub | -3.49 | 66.2 | 109.0 | 36.8 | 45.1 | 257.0 | ||||
| EBITDA, bln rub | ? | 82.0 | 93.3 | 127.3 | 62.1 | 59.7 | 342.3 | |||
| Net profit, bln rub | ? | 9.19 | 67.0 | 97.8 | 38.4 | 58.6 | 261.8 | |||
| OCF, bln rub | ? | 85.0 | 8.41 | 181.4 | 21.3 | 116.2 | 327.3 | |||
| CAPEX, bln rub | ? | 8.19 | 6.10 | 8.92 | 7.61 | 7.38 | 30.0 | |||
| FCF, bln rub | ? | 76.8 | 2.31 | 172.5 | 13.7 | 108.8 | 297.2 | |||
| Dividend payout, bln rub | 25.8 | 28.6 | 28.7 | 28.7 | 28.6 | 114.6 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 281.1% | 42.6% | 29.4% | 74.7% | 48.8% | 43.8% | ||||
| OPEX, bln rub | 227.9 | 217.3 | 216.8 | 216.4 | 225.7 | 876.2 | ||||
| Cost of production, bln rub | 35.6 | 32.1 | 38.8 | 35.7 | 34.0 | 140.5 | ||||
| R&D, bln rub | 70.4 | 67.0 | 62.5 | 65.5 | 68.6 | 263.7 | ||||
| Interest expenses, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Assets, bln rub | 2 980 | 2 936 | 3 045 | 2 974 | 3 110 | 3 110 | ||||
| Net Assets, bln rub | ? | 2 355 | 2 346 | 2 421 | 2 433 | 2 477 | 2 477 | |||
| Debt, bln rub | 50.6 | 47.2 | 51.9 | 48.2 | 47.0 | 47.0 | ||||
| Cash, bln rub | 884.5 | 797.6 | 825.4 | 869.0 | 577.8 | 577.8 | ||||
| Net debt, bln rub | -833.9 | -750.4 | -773.5 | -820.8 | -530.8 | -530.8 | ||||
| Ordinary share price, rub | 79.3 | 86.2 | 83.8 | 79.2 | 75.6 | 83.5 | ||||
| Number of ordinary shares, mln | 95.7 | 95.4 | 95.7 | 95.7 | 95.4 | 95.4 | ||||
| Market cap, bln rub | 7 585 | 8 220 | 8 018 | 7 581 | 7 213 | 7 961 | ||||
| EV, bln rub | ? | 6 751 | 7 469 | 7 245 | 6 760 | 6 682 | 7 430 | |||
| Book value, bln rub | 1 779 | 1 776 | 1 860 | 1 880 | 1 509 | 1 509 | ||||
| EPS, rub | ? | 0.10 | 0.70 | 1.02 | 0.40 | 0.61 | 2.74 | |||
| FCF/share, rub | 0.80 | 0.02 | 1.80 | 0.14 | 1.14 | 3.12 | ||||
| BV/share, rub | 18.6 | 18.6 | 19.4 | 19.6 | 15.8 | 15.8 | ||||
| EBITDA margin, % | ? | 28.2% | 29.6% | 34.9% | 21.5% | 19.6% | 26.9% | |||
| Net margin, % | ? | 3.16% | 21.2% | 26.8% | 13.3% | 19.2% | 20.6% | |||
| FCF yield, % | ? | 5.09% | 3.53% | 4.56% | 3.50% | 4.12% | 3.73% | |||
| ROE, % | ? | 11.9% | 8.03% | 7.86% | 8.73% | 10.6% | 10.6% | |||
| ROA, % | ? | 9.40% | 6.41% | 6.25% | 7.14% | 8.42% | 8.42% | |||
| P/E | ? | 27.1 | 43.7 | 42.1 | 35.7 | 27.5 | 30.4 | |||
| P/FCF | 19.7 | 28.4 | 21.9 | 28.6 | 24.3 | 26.8 | ||||
| P/S | ? | 4.64 | 6.42 | 6.32 | 6.02 | 5.66 | 6.25 | |||
| P/BV | ? | 4.26 | 4.63 | 4.31 | 4.03 | 4.78 | 5.27 | |||
| EV/EBITDA | ? | 13.5 | 21.4 | 19.7 | 18.5 | 19.5 | 21.7 | |||
| Debt/EBITDA | -1.67 | -2.15 | -2.11 | -2.25 | -1.55 | -1.55 | ||||
| R&D/CAPEX, % | 860.4% | 1 099% | 700.9% | 860.4% | 930.2% | 878.7% | ||||
| CAPEX/Revenue, % | 2.82% | 1.93% | 2.45% | 2.64% | 2.42% | 2.36% | ||||
| Dolby Laboratories shareholders | ||||||||||
